These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26122040)
21. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis. Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779 [TBL] [Abstract][Full Text] [Related]
22. c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation. He X; Zheng Z; Song T; Wei C; Ma H; Ma Q; Zhang Y; Xu Y; Shi W; Ye Q; Zhong H Oncogene; 2010 Apr; 29(15):2238-51. PubMed ID: 20101225 [TBL] [Abstract][Full Text] [Related]
23. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells. Kim Y; Kim H; Jang SW; Ko J Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway. Hou X; Zhao M; Wang T; Zhang G Oncol Rep; 2014 Mar; 31(3):1175-82. PubMed ID: 24366110 [TBL] [Abstract][Full Text] [Related]
25. Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of ERα inhibits proliferation and invasion of MKN28 gastric cancer cells by suppressing β-catenin. Zhou J; Teng R; Xu C; Wang Q; Guo J; Xu C; Li Z; Xie S; Shen J; Wang L Oncol Rep; 2013 Oct; 30(4):1622-30. PubMed ID: 23843035 [TBL] [Abstract][Full Text] [Related]
27. Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells. Adler D; Langer B; Lindstrot A; Florin A; Bosserhoff A; Buettner R; Wernert N Oncol Rep; 2011 Apr; 25(4):1125-9. PubMed ID: 21258770 [TBL] [Abstract][Full Text] [Related]
28. BCAS2 Enhances Carcinogenic Effects of Estrogen Receptor Alpha in Breast Cancer Cells. Salmerón-Hernández Á; Noriega-Reyes MY; Jordan A; Baranda-Avila N; Langley E Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813351 [TBL] [Abstract][Full Text] [Related]
30. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells. Phelps M; Darley M; Primrose JN; Blaydes JP Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288 [TBL] [Abstract][Full Text] [Related]
31. Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1. Du Y; Shi X; Ma W; Wen P; Yu P; Wang X; Fang P; Chen A; Gao Z; Cui K Pharmacol Res; 2021 Jul; 169():105648. PubMed ID: 33965509 [TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function. Felzen V; Hiebel C; Koziollek-Drechsler I; Reißig S; Wolfrum U; Kögel D; Brandts C; Behl C; Morawe T Cell Death Dis; 2015 Jul; 6(7):e1812. PubMed ID: 26158518 [TBL] [Abstract][Full Text] [Related]
33. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions. Tong Z; Liu Y; Yu X; Martinez JD; Xu J J Biol Chem; 2019 Dec; 294(51):19667-19682. PubMed ID: 31744881 [TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells. Hinsche O; Girgert R; Emons G; Gründker C Int J Oncol; 2015 Feb; 46(2):878-84. PubMed ID: 25420519 [TBL] [Abstract][Full Text] [Related]
35. IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells. Cervantes-Badillo MG; Paredes-Villa A; Gómez-Romero V; Cervantes-Roldán R; Arias-Romero LE; Villamar-Cruz O; González-Montiel M; Barrios-García T; Cabrera-Quintero AJ; Rodríguez-Gómez G; Cancino-Villeda L; Zentella-Dehesa A; León-Del-Río A Front Endocrinol (Lausanne); 2020; 11():568375. PubMed ID: 33117284 [TBL] [Abstract][Full Text] [Related]
36. MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma. Wei S; Liu W; Sun N; Wu Y; Song H; Wang C; Wang S; Zou R; Lin L; Zeng K; Zhou B; Wang M; Luan R; Yang F; Zhao Y Cancer Sci; 2021 May; 112(5):1865-1877. PubMed ID: 33544437 [TBL] [Abstract][Full Text] [Related]
37. Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro. Ai J; Li W; Zeng R; Xie Z; Liu H; Hou M; Tan G Biomed Pharmacother; 2016 Oct; 83():1022-1031. PubMed ID: 27525970 [TBL] [Abstract][Full Text] [Related]
38. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences. Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188 [TBL] [Abstract][Full Text] [Related]
39. Transcription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cells. Ma H; Yao Y; Wang C; Zhang L; Cheng L; Wang Y; Wang T; Liang E; Jia H; Ye Q; Hou M; Feng F Onco Targets Ther; 2016; 9():3451-63. PubMed ID: 27366082 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-106a suppresses proliferation, migration, and invasion of bladder cancer cells by modulating MAPK signaling, cell cycle regulators, and Ets-1-mediated MMP-2 expression. Shin SS; Park SS; Hwang B; Kim WT; Choi YH; Kim WJ; Moon SK Oncol Rep; 2016 Oct; 36(4):2421-9. PubMed ID: 27513725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]